{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:52:04Z","timestamp":1788382324326,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the discipline innovation and development plan of Tangdu hospital-major program of clinical research","award":["2021LCYJ002"],"award-info":[{"award-number":["2021LCYJ002"]}]},{"name":"the National Key Research and Development Program","award":["2022YFC3501304"],"award-info":[{"award-number":["2022YFC3501304"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82271378"],"award-info":[{"award-number":["82271378"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"DOI":"10.1007\/s12035-024-04352-9","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T15:01:57Z","timestamp":1721228517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Exploring the Roles of m6A-Modified circRNAs in Myasthenia Gravis Based on Multi-Omics Analysis"],"prefix":"10.1007","author":[{"given":"Shuang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,17]]},"reference":[{"key":"4352_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/B978-0-12-823912-4.00026-8","volume":"200","author":"MR Tannemaat","year":"2024","unstructured":"Tannemaat MR, Huijbers MG, Verschuuren J (2024) Myasthenia gravis-pathophysiology, diagnosis, and treatment. Handb Clin Neurol 200:283\u2013305","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"4352_CR2","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1186\/s12967-023-04421-y","volume":"21","author":"H Zhong","year":"2023","unstructured":"Zhong H et al (2023) Peripheral immune landscape for hypercytokinemia in myasthenic crisis utilizing single-cell transcriptomics. J Transl Med 21(1):564","journal-title":"J Transl Med"},{"issue":"2","key":"4352_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41582-023-00916-w","volume":"20","author":"R Iorio","year":"2024","unstructured":"Iorio R (2024) Myasthenia gravis: the changing treatment landscape in the era of molecular therapies. Nat Rev Neurol 20(2):84\u201398","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"4352_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S1474-4422(21)00357-4","volume":"21","author":"MG Huijbers","year":"2022","unstructured":"Huijbers MG et al (2022) Advances in the understanding of disease mechanisms of autoimmune neuromuscular junction disorders. Lancet Neurol 21(2):163\u2013175","journal-title":"Lancet Neurol"},{"issue":"4","key":"4352_CR5","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cell.2019.03.046","volume":"177","author":"CX Liu","year":"2019","unstructured":"Liu CX et al (2019) Structure and degradation of circular RNAs regulate PKR activation in innate immunity. Cell 177(4):865-880.e21","journal-title":"Cell"},{"issue":"11","key":"4352_CR6","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/cbin.11676","volume":"45","author":"X Lai","year":"2021","unstructured":"Lai X et al (2021) Upregulation of circ-FBL promotes myogenic proliferation in myasthenia gravis by regulation of miR-133\/PAX7. Cell Biol Int 45(11):2287\u20132293","journal-title":"Cell Biol Int"},{"key":"4352_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108676","volume":"224","author":"J Lv","year":"2021","unstructured":"Lv J et al (2021) Peripheral blood hsa-circRNA5333-4: a novel biomarker for myasthenia gravis. Clin Immunol 224:108676","journal-title":"Clin Immunol"},{"issue":"3","key":"4352_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188904","volume":"1878","author":"SC Selvakumar","year":"2023","unstructured":"Selvakumar SC, Preethi KA, Sekar D (2023) MicroRNAs as important players in regulating cancer through PTEN\/PI3K\/AKT signalling pathways. Biochim Biophys Acta Rev Cancer 1878(3):188904","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"4352_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.placenta.2024.05.135","volume":"153","author":"SC Selvakumar","year":"2024","unstructured":"Selvakumar SC, Preethi KA, Sekar D (2024) MicroRNA-510-3p regulated vascular dysfunction in preeclampsia by targeting vascular endothelial growth factor A (VEGFA) and its signaling axis. Placenta 153:31\u201352","journal-title":"Placenta"},{"issue":"4","key":"4352_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2217\/epi-2023-0363","volume":"16","author":"A Kp","year":"2024","unstructured":"Kp A, Kaliaperumal K, Sekar D (2024) microRNAs and their therapeutic strategy in phase I and phase II clinical trials. Epigenomics 16(4):259\u2013271","journal-title":"Epigenomics"},{"issue":"1","key":"4352_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-020-01224-3","volume":"19","author":"L Zhang","year":"2020","unstructured":"Zhang L et al (2020) The role of N(6)-methyladenosine (m(6)A) modification in the regulation of circRNAs. Mol Cancer 19(1):105","journal-title":"Mol Cancer"},{"issue":"4","key":"4352_CR12","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.160003","volume":"6","author":"G Cao","year":"2016","unstructured":"Cao G et al (2016) Recent advances in dynamic m6A RNA modification. Open Biol 6(4):160003","journal-title":"Open Biol"},{"issue":"13","key":"4352_CR13","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.2217\/epi-2020-0131","volume":"12","author":"D Sekar","year":"2020","unstructured":"Sekar D, Lakshmanan G (2020) Methylation of N6-adenosine (m6A) modification in miRNAs and its implications in immunity. Epigenomics 12(13):1083\u20131085","journal-title":"Epigenomics"},{"issue":"1","key":"4352_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13075-022-02732-x","volume":"24","author":"X Zhao","year":"2022","unstructured":"Zhao X et al (2022) N6-methyladenosine-dependent modification of circGARS acts as a new player that promotes SLE progression through the NF-\u03baB\/A20 axis. Arthritis Res Ther 24(1):37","journal-title":"Arthritis Res Ther"},{"key":"4352_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jaut.2017.05.005","volume":"82","author":"S Mamrut","year":"2017","unstructured":"Mamrut S et al (2017) Methylome and transcriptome profiling in myasthenia gravis monozygotic twins. J Autoimmun 82:62\u201373","journal-title":"J Autoimmun"},{"issue":"1","key":"4352_CR16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12967-023-03947-5","volume":"21","author":"S Li","year":"2023","unstructured":"Li S et al (2023) Landscape analysis of m6A modification regulators related biological functions and immune characteristics in myasthenia gravis. J Transl Med 21(1):166","journal-title":"J Transl Med"},{"issue":"5","key":"4352_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G et al (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16(5):284\u2013287","journal-title":"OMICS"},{"issue":"7","key":"4352_CR18","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1080\/15476286.2019.1600395","volume":"16","author":"M Liu","year":"2019","unstructured":"Liu M et al (2019) Circbank: a comprehensive database for circRNA with standard nomenclature. RNA Biol 16(7):899\u2013905","journal-title":"RNA Biol"},{"issue":"D1","key":"4352_CR19","doi-asserted-by":"publisher","first-page":"D296","DOI":"10.1093\/nar\/gkx1067","volume":"46","author":"CH Chou","year":"2018","unstructured":"Chou CH et al (2018) miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res 46(D1):D296-d302","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"4352_CR20","doi-asserted-by":"publisher","first-page":"D902","DOI":"10.1093\/nar\/gkw1038","volume":"45","author":"J Wang","year":"2017","unstructured":"Wang J et al (2017) NSDNA: a manually curated database of experimentally supported ncRNAs associated with nervous system diseases. Nucleic Acids Res 45(D1):D902-d907","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"4352_CR21","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1007\/s12035-021-02426-6","volume":"58","author":"S Li","year":"2021","unstructured":"Li S et al (2021) Construction of lncRNA-mediated ceRNA network for investigating immune pathogenesis of ischemic stroke. Mol Neurobiol 58(9):4758\u20134769","journal-title":"Mol Neurobiol"},{"key":"4352_CR22","doi-asserted-by":"publisher","first-page":"1026578","DOI":"10.3389\/fcell.2022.1026578","volume":"10","author":"S Li","year":"2022","unstructured":"Li S et al (2022) Identification of immune characteristic landscapes related to autophagy in ischemic stroke. Front Cell Dev Biol 10:1026578","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"4352_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw104","volume":"44","author":"Y Zhou","year":"2016","unstructured":"Zhou Y et al (2016) SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features. Nucleic Acids Res 44(10):e91","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"4352_CR24","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1001\/jamaneurol.2022.2887","volume":"79","author":"F Piehl","year":"2022","unstructured":"Piehl F et al (2022) Efficacy and safety of rituximab for new-onset generalized myasthenia gravis: the RINOMAX randomized clinical trial. JAMA Neurol 79(11):1105\u20131112","journal-title":"JAMA Neurol"},{"issue":"12","key":"4352_CR25","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","volume":"16","author":"JF Howard Jr","year":"2017","unstructured":"Howard JF Jr et al (2017) Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. Lancet Neurol 16(12):976\u2013986","journal-title":"Lancet Neurol"},{"issue":"7","key":"4352_CR26","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S1474-4422(21)00159-9","volume":"20","author":"JF Howard Jr","year":"2021","unstructured":"Howard JF Jr et al (2021) Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial. Lancet Neurol 20(7):526\u2013536","journal-title":"Lancet Neurol"},{"issue":"1","key":"4352_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e23694","volume":"10","author":"RJ Zhao","year":"2024","unstructured":"Zhao RJ, Zhang WY, Fan XX (2024) Circular RNAs: potential biomarkers and therapeutic targets for autoimmune diseases. Heliyon 10(1):e23694","journal-title":"Heliyon"},{"issue":"7","key":"4352_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1318","volume":"13","author":"Y Shao","year":"2023","unstructured":"Shao Y et al (2023) ALKBH5\/YTHDF2-mediated m6A modification of circAFF2 enhances radiosensitivity of colorectal cancer by inhibiting cullin neddylation. Clin Transl Med 13(7):e1318","journal-title":"Clin Transl Med"},{"issue":"34","key":"4352_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304895","volume":"10","author":"Z Wu","year":"2023","unstructured":"Wu Z et al (2023) m6A-modified circTET2 interacting with HNRNPC regulates fatty acid oxidation to promote the proliferation of chronic lymphocytic leukemia. Adv Sci (Weinh) 10(34):e2304895","journal-title":"Adv Sci (Weinh)"},{"issue":"4","key":"4352_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.11","volume":"49","author":"K Hyun","year":"2017","unstructured":"Hyun K et al (2017) Writing, erasing and reading histone lysine methylations. Exp Mol Med 49(4):e324","journal-title":"Exp Mol Med"},{"issue":"4","key":"4352_CR31","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.molcel.2012.11.006","volume":"48","author":"JC Black","year":"2012","unstructured":"Black JC, Van Rechem C, Whetstine JR (2012) Histone lysine methylation dynamics: establishment, regulation, and biological impact. Mol Cell 48(4):491\u2013507","journal-title":"Mol Cell"},{"issue":"5","key":"4352_CR32","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cell.2007.05.018","volume":"129","author":"JL Bos","year":"2007","unstructured":"Bos JL, Rehmann H, Wittinghofer A (2007) GEFs and GAPs: critical elements in the control of small G proteins. Cell 129(5):865\u2013877","journal-title":"Cell"},{"issue":"6508","key":"4352_CR33","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.aba4904","volume":"369","author":"J Brito Querido","year":"2020","unstructured":"Brito Querido J et al (2020) Structure of a human 48S translational initiation complex. Science 369(6508):1220\u20131227","journal-title":"Science"},{"issue":"7483","key":"4352_CR34","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay Y, Rinn J, Pandolfi PP (2014) The multilayered complexity of ceRNA crosstalk and competition. Nature 505(7483):344\u2013352","journal-title":"Nature"},{"issue":"9","key":"4352_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003777","volume":"9","author":"J Salzman","year":"2013","unstructured":"Salzman J et al (2013) Cell-type specific features of circular RNA expression. PLoS Genet 9(9):e1003777","journal-title":"PLoS Genet"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04352-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04352-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04352-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T15:13:20Z","timestamp":1721229200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04352-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":35,"alternative-id":["4352"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04352-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,17]]},"assertion":[{"value":"21 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the Ethics Committee of Tangdu Hospital, the Fourth Military Medical University (202006\u201323). The patients\/participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}